References:
1.National Health Commission of the People’s Republic of China. Diagnosis and treatment of COVID-19 (trial version 6)[EB/OL]. [2020-02-18].
(http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdf)
2.Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet 2015;386:995-1007.
3.World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance. January 28, 2020 (https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf)
4.National Health Commission of the People’s Republic of China. Guidelines for the Prevention and Control of COVID-19 in Home isolation Medical observation (trial) [EB/OL]. [2020-02-18]. (http://www.nhc.gov.cn/yzygj/s7659/202002/cf80b05048584f8da9b4a54871c44b26.shtml.)
5.Pu Jie, Liu Xinghui. Suggestions for the classification and management of perinatal prevention and control during the epidemic of new coronavirus pneumonia [J/OL]. Chin J Obstet Gynecol
, 2020,55 (2020-02-25). http://rs.yiigle.com/yufabiao/1182682.htm. DOI: 10.3760/cma.j.cn112141-20200221-00123.
6.Ong SWX, Tan YK, Chia PY, et al. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient [published online ahead of print, 2020 Mar 4]. JAMA. 2020;10.1001/jama.2020.3227. doi:10.1001/jama.2020.3227